600064 南京高科
2025/06 - 中期
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入1,959,98287.39%1,980,2574,733,0384,490,0614,934,527
减:营业总成本1,834,95182.07%1,982,3134,564,9614,095,9564,688,834
    其中:营业成本1,516,12774.83%1,543,1954,143,8663,649,0473,797,987
               财务费用91,726-16.54%209,022220,384177,024203,312
               资产减值损失----(773,775)(608,242)(2,743)(72,938)
公允价值变动收益3,163-102.81%24,779(140,770)(242,623)(34,410)
投资收益1,258,23619.01%2,293,6151,964,6752,405,3342,367,123
    其中:对联营企业和合营企业的投资收益1,227,03910.78%2,129,4471,829,7262,096,3341,686,458
营业利润1,368,02340.14%1,504,9841,367,5402,650,4142,679,073
利润总额1,425,98346.06%1,507,9231,369,9622,651,6352,679,209
减:所得税费用30,550-157.31%(133,472)(112,586)171,739276,924
净利润1,395,43335.53%1,641,3951,482,5492,479,8952,402,285
减:非控股权益14,422109.64%(83,835)(77,597)77,52250,232
股东净利润1,381,01235.04%1,725,2301,560,1462,402,3742,352,053

市场价值指针
每股收益 (元) *0.79835.03%0.9970.9021.3881.359
每股派息 (元) *----0.3000.2800.4200.600
每股净资产 (元) *10.8923.43%10.86910.1369.572--
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容